skip to content

Roche receives positive CHMP opinion for Evrysdi, the first and only at home spinal muscular atrophy (SMA) treatment with proven efficacy in adults, children and infants two months and older

Media

Media releases
view all

stay updated

get the latest news and updates to your inbox.